麻豆传媒

The Canadian Center for Vaccinology is looking for 2-month-old healthy infants to examine the safety and effectiveness of a new聽pneumococcal vaccine. If you are interested, please contact:聽Aimee.GonzalezdeArmas@iwk.nshealth.ca. 聽

Purpose of the Study:

Pneumococcal vaccine is routinely given to infants in Canada to protect them against pneumococcal disease which can result in serious infections. Pneumococcal disease is caused by the bacteria聽Streptococcus pneumoniae,聽or 鈥減neumococcus鈥�.聽 These bacteria can cause infection of the middle ear (otitis), of the lungs (pneumonia), or become more serious. In Nova Scotia and most other provinces/territories in Canada, a vaccine called Prevnar-13鈩�, which protects against 13 types of pneumococcal infection, is given as 3 injections at 2, 4, and 12 months of age. There is a new vaccine that protects against 8 additional types. In this study, we are looking to compare the safety and effectiveness of the new vaccine that protects against 21 types with the routine vaccine called Prevnar-13鈩�.

Eligibility:

Your child can take part in this study if:

• He/she is healthy
• He/she is 2 months of age
• He/she has not yet received their routine vaccines
• You are able to understand the study and procedures, the risks and benefits involved, and agree for your child to take part by signing the consent form

What Will I Have to Do?

Your child will have a total of 6 visits to the IWK and you will be asked to complete 5 phone calls over a 16-19 month period. The visits and phone calls will take around 4-5 hours over the entire study period.

If you are interested in participating or would like to know more please contact:
Aimee Gonzalez de Armas
Email: Aimee.GonzalezdeArmas@iwk.nshealth.ca
Phone: 902-470-7015

To view the study on our website, please visit:聽